Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1496060302', 'doi': None, 'title': 'Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.', 'display_name': 'Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.', 'publication_year': 1991, 'publication_date': '1991-02-15', 'ids': {'openalex': 'https://openalex.org/W1496060302', 'mag': '1496060302', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/1705167'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/1705167', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5054370710', 'display_name': 'Scott H. Kaufmann', 'orcid': 'https://orcid.org/0000-0002-4900-7145'}, 'institutions': [{'id': 'https://openalex.org/I4210150714', 'display_name': 'Johns Hopkins Hospital', 'ror': 'https://ror.org/05cb1k848', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2799853436', 'https://openalex.org/I4210150714']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'S H Kaufmann', 'raw_affiliation_strings': ['Oncology Center, Johns Hopkins Hospital, Baltimore, Maryland.'], 'affiliations': [{'raw_affiliation_string': 'Oncology Center, Johns Hopkins Hospital, Baltimore, Maryland.', 'institution_ids': ['https://openalex.org/I4210150714']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5054370710'], 'corresponding_institution_ids': ['https://openalex.org/I4210150714'], 'apc_list': None, 'apc_paid': None, 'fwci': 5.845, 'has_fulltext': False, 'cited_by_count': 165, 'citation_normalized_percentile': {'value': 0.91007, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '51', 'issue': '4', 'first_page': '1129', 'last_page': '36'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T13160', 'display_name': 'Synthesis and Biological Evaluation', 'score': 0.9878, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T12334', 'display_name': 'Lung Cancer Research Studies', 'score': 0.9807, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/camptothecin', 'display_name': 'Camptothecin', 'score': 0.8151855}, {'id': 'https://openalex.org/keywords/aphidicolin', 'display_name': 'Aphidicolin', 'score': 0.62442213}, {'id': 'https://openalex.org/keywords/amsacrine', 'display_name': 'Amsacrine', 'score': 0.6048635}, {'id': 'https://openalex.org/keywords/topoisomerase-inhibitor', 'display_name': 'Topoisomerase inhibitor', 'score': 0.54015434}, {'id': 'https://openalex.org/keywords/daunorubicin', 'display_name': 'Daunorubicin', 'score': 0.5331164}, {'id': 'https://openalex.org/keywords/topotecan', 'display_name': 'Topotecan', 'score': 0.46635595}], 'concepts': [{'id': 'https://openalex.org/C2778119113', 'wikidata': 'https://www.wikidata.org/wiki/Q418817', 'display_name': 'Etoposide', 'level': 3, 'score': 0.90567875}, {'id': 'https://openalex.org/C147897179', 'wikidata': 'https://www.wikidata.org/wiki/Q407828', 'display_name': 'Topoisomerase', 'level': 3, 'score': 0.85957205}, {'id': 'https://openalex.org/C2779682216', 'wikidata': 'https://www.wikidata.org/wiki/Q419964', 'display_name': 'Camptothecin', 'level': 2, 'score': 0.8151855}, {'id': 'https://openalex.org/C2776253266', 'wikidata': 'https://www.wikidata.org/wiki/Q414000', 'display_name': 'Aphidicolin', 'level': 4, 'score': 0.62442213}, {'id': 'https://openalex.org/C109316439', 'wikidata': 'https://www.wikidata.org/wiki/Q246181', 'display_name': 'Cytotoxicity', 'level': 3, 'score': 0.61201054}, {'id': 'https://openalex.org/C2780500152', 'wikidata': 'https://www.wikidata.org/wiki/Q2784004', 'display_name': 'Amsacrine', 'level': 4, 'score': 0.6048635}, {'id': 'https://openalex.org/C2778041864', 'wikidata': 'https://www.wikidata.org/wiki/Q180983', 'display_name': 'Cytarabine', 'level': 3, 'score': 0.5548872}, {'id': 'https://openalex.org/C2778616834', 'wikidata': 'https://www.wikidata.org/wiki/Q281044', 'display_name': 'Topoisomerase inhibitor', 'level': 4, 'score': 0.54015434}, {'id': 'https://openalex.org/C2781021840', 'wikidata': 'https://www.wikidata.org/wiki/Q411659', 'display_name': 'Daunorubicin', 'level': 3, 'score': 0.5331164}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.47106856}, {'id': 'https://openalex.org/C2781209748', 'wikidata': 'https://www.wikidata.org/wiki/Q419953', 'display_name': 'Topotecan', 'level': 3, 'score': 0.46635595}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.46101987}, {'id': 'https://openalex.org/C2778143360', 'wikidata': 'https://www.wikidata.org/wiki/Q421193', 'display_name': 'Podophyllotoxin', 'level': 2, 'score': 0.45736015}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.40628904}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.40589136}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.38592282}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.31603545}, {'id': 'https://openalex.org/C2756471', 'wikidata': 'https://www.wikidata.org/wiki/Q206286', 'display_name': 'DNA polymerase', 'level': 3, 'score': 0.30299336}, {'id': 'https://openalex.org/C2778461978', 'wikidata': 'https://www.wikidata.org/wiki/Q29496', 'display_name': 'Leukemia', 'level': 2, 'score': 0.30262935}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.2514534}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.18249762}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.1589981}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.14169532}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.06631935}], 'mesh': [{'descriptor_ui': 'D002166', 'descriptor_name': 'Camptothecin', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D015473', 'descriptor_name': 'Leukemia, Promyelocytic, Acute', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D059005', 'descriptor_name': 'Topoisomerase II Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000677', 'descriptor_name': 'Amsacrine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000677', 'descriptor_name': 'Amsacrine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016590', 'descriptor_name': 'Aphidicolin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015153', 'descriptor_name': 'Blotting, Western', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002166', 'descriptor_name': 'Camptothecin', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D002166', 'descriptor_name': 'Camptothecin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003114', 'descriptor_name': 'Colony-Forming Units Assay', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003513', 'descriptor_name': 'Cycloheximide', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D003513', 'descriptor_name': 'Cycloheximide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004257', 'descriptor_name': 'DNA Polymerase II', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D004257', 'descriptor_name': 'DNA Polymerase II', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004261', 'descriptor_name': 'DNA Replication', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D004261', 'descriptor_name': 'DNA Replication', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003630', 'descriptor_name': 'Daunorubicin', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D003630', 'descriptor_name': 'Daunorubicin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003839', 'descriptor_name': 'Deoxyadenosines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D003839', 'descriptor_name': 'Deoxyadenosines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004004', 'descriptor_name': 'Dichlororibofuranosylbenzimidazole', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D004004', 'descriptor_name': 'Dichlororibofuranosylbenzimidazole', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004224', 'descriptor_name': 'Diterpenes', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D004224', 'descriptor_name': 'Diterpenes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004357', 'descriptor_name': 'Drug Synergism', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005047', 'descriptor_name': 'Etoposide', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D005047', 'descriptor_name': 'Etoposide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015473', 'descriptor_name': 'Leukemia, Promyelocytic, Acute', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009153', 'descriptor_name': 'Mutagens', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D009153', 'descriptor_name': 'Mutagens', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012313', 'descriptor_name': 'RNA', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D012313', 'descriptor_name': 'RNA', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019772', 'descriptor_name': 'Topotecan', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014407', 'descriptor_name': 'Tumor Cells, Cultured', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/1705167', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.45}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2420213919', 'https://openalex.org/W2396796971', 'https://openalex.org/W2344056970', 'https://openalex.org/W2170830299', 'https://openalex.org/W2118553080', 'https://openalex.org/W2062228200', 'https://openalex.org/W2013317272', 'https://openalex.org/W2001410279', 'https://openalex.org/W1995556774', 'https://openalex.org/W1496060302'], 'abstract_inverted_index': {'To': [0, 176], 'search': [1], 'for': [2, 36, 200], 'possible': [3], 'synergy': [4], 'between': [5], 'topoisomerase': [6], '(topo)': [7], 'II-directed': [8, 111, 189], 'chemotherapeutic': [9], 'agents': [10], 'and': [11, 91, 105, 138, 173, 242], 'topo': [12, 110, 148, 162, 188], 'I-directed': [13], 'agents,': [14, 190], 'IL-60': [15], 'human': [16], 'progranulocytic': [17], 'leukemia': [18], 'cells': [19, 35, 51, 72, 215, 234], 'were': [20, 198], 'incubated': [21], 'with': [22, 39, 63], 'etoposide': [23, 42, 79, 159], 'in': [24, 44, 57], 'the': [25, 45, 50, 68, 101, 156, 179, 185, 210, 229], 'absence': [26], 'or': [27, 195, 226], 'presence': [28], 'of': [29, 33, 47, 49, 70, 78, 103, 144, 158, 170, 187, 192, 205, 212, 222, 231, 245], 'camptothecin': [30], '(CPT).': [31], 'Treatment': [32], 'HL-60': [34, 214, 233], '1': [37, 64], 'h': [38], '15-20': [40], 'microM': [41, 65, 90], 'resulted': [43], 'death': [46], '99-99.9%': [48], 'as': [52, 73, 75, 86, 88, 235, 237], 'assessed': [53], 'by': [54, 181], 'colony': [55], 'formation': [56, 143], 'soft': [58], 'agar.': [59], 'Unexpectedly,': [60], 'simultaneous': [61], 'incubation': [62], 'CPT': [66, 84, 98, 115, 152, 165, 183], 'increased': [67], 'survival': [69, 211, 230], 'etoposide-treated': [71, 213, 232], 'much': [74, 236], '30-fold.': [76], 'Inhibition': [77], 'cytotoxicity': [80, 102, 186], 'was': [81, 92], 'observed': [82], 'at': [83, 95], 'concentrations': [85], 'low': [87], '0.01': [89], 'one-half': [93], 'maximal': [94], '0.1': [96], 'microM.': [97], 'also': [99], 'antagonized': [100], "4'-(9-acridinylamino)methanesulfon-M-anisidide": [104], 'daunorubicin,': [106], 'two': [107], 'structurally': [108], 'unrelated': [109], 'agents.': [112], 'Topotecan,': [113], 'a': [114, 124, 167], 'analogue': [116], 'currently': [117], 'undergoing': [118], 'Phase': [119], 'I': [120], 'clinical': [121], 'trials,': [122], 'had': [123], 'similar': [125], 'effect.': [126], 'Studies': [127], 'using': [128], 'an': [129, 203], 'alkaline': [130], 'unwinding': [131], 'assay': [132], '(to': [133, 141], 'measure': [134], 'DNA': [135, 172, 193, 207], 'strand': [136], 'breaks)': [137], 'Western': [139], 'blotting': [140], 'assess': [142, 178], 'covalent': [145], 'adducts': [146], 'involving': [147], 'II)': [149], 'revealed': [150], 'that': [151], 'did': [153], 'not': [154], 'alter': [155], 'ability': [157], 'to': [160], 'stabilize': [161], 'II-DNA': [163], 'adducts.': [164], 'is': [166], 'potent': [168], 'inhibitor': [169, 204], 'both': [171], 'RNA': [174, 196, 223], 'synthesis.': [175], 'further': [177], 'mechanism': [180], 'which': [182], 'diminished': [184], 'inhibitors': [191, 221], 'synthesis': [194, 197, 224], 'substituted': [199], 'CPT.': [201], 'Aphidicolin,': [202], 'replicative': [206], 'polymerases,': [208], 'enhanced': [209, 228], 'less': [216], 'than': [217], '3-fold.': [218], 'In': [219], 'contrast,': [220], '(cordycepin': [225], '5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole)': [227], '20-fold.': [238], 'The': [239], 'potential': [240], 'biological': [241], 'therapeutic': [243], 'implications': [244], 'these': [246], 'results': [247], 'are': [248], 'discussed.': [249]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1496060302', 'counts_by_year': [{'year': 2021, 'cited_by_count': 3}, {'year': 2019, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 3}, {'year': 2014, 'cited_by_count': 2}, {'year': 2013, 'cited_by_count': 1}, {'year': 2012, 'cited_by_count': 1}], 'updated_date': '2024-12-17T02:50:44.158855', 'created_date': '2016-06-24'}